Introduction {#sec1}
============

Congenital heart diseases (CHD) refer to a group of structural heart defects that are resulted from abnormal cardiac development. The incidence of CHD is estimated to be approximately 1% in newborns, and despite rapid advances in surgical treatments and interventional therapies over the past few decades, CHD is still the primary non-infectious cause of infant mortality worldwide \[[@B1]\]. Moreover, its associated complications such as heart failure, arrhythmia and sudden cardiac death may occur even after effective correction of cardiac abnormalities \[[@B2],[@B3]\]. Until now, the exact cause of CHD is still largely unclear despite extensive investigations. Nevertheless, mounting evidence supports that genetic factors play a crucial part in its development. First, family clustering of CHD with variable phenotypes is not uncommon, and descendants of CHD patients suffer a higher risk of developing cardiac malformations compared with the general population \[[@B4],[@B5]\]. Second, multiple genetic variants have been found to be associated with an increased risk of CHD \[[@B6]\]. Overall, these findings jointly indicate that genetic predisposition to CHD is vital for its occurrence and development.

Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) play central roles in the regulation of folate metabolism and homocysteine synthesis \[[@B10]\]. Previous studies have shown that taking folate supplements during pregnancy could significantly reduce the risk of cardiovascular congenital malformations in newborns \[[@B11],[@B12]\]. Consequently, functional *MTHFR* and *MTRR* polymorphisms, which were known to affect plasma folate levels, were considered to be ideal candidate genetic biomarkers of CHD.

So far, numerous studies have been conducted to assess the roles of *MTHFR* and *MTRR* gene polymorphisms in CHD, but the results of these studies were controversial \[[@B13]\]. Therefore, we conducted the present meta-analysis to better evaluate potential associations of *MTHFR* and *MTRR* gene polymorphisms with the risk of CHD.

Materials and methods {#sec2}
=====================

Literature search and inclusion criteria {#sec2-1}
----------------------------------------

The current meta-analysis was adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement \[[@B17]\]. A systematic literature search of PubMed, Medline, Embase and China National Knowledge Infrastructure (CNKI) was performed to retrieve all relevant articles. The key words used in this literature search included: '5-methyltetrahydrofolate-homocysteine methyltransferase reductase', 'methionine synthase reductase', 'MTRR', 'MSR', 'methylenetetrahydrofolate reductase', 'MTHFR', 'polymorphism', 'variant', 'mutation', 'genotype', 'allele', 'congenital heart disease', 'congenital heart defect' and 'congenital cardiovascular malformation' (see Supplementary File S1). To identify other potentially relevant publications, we also reviewed the reference lists of all retrieved articles.

Eligible studies of the current meta-analysis must met all the following criteria: (1) evaluate potential associations of *MTRR* and/or *MTHFR* gene polymorphisms with the risk of CHD; (2) provide sufficient data to calculate odds ratios (ORs) and 95% confidence intervals (CIs); (3) full text in Chinese or English available. For duplicate reports, only the study with the largest sample size was included. Reviews, comments, letters and family-based association studies were excluded.

Data extraction and quality assessment {#sec2-2}
--------------------------------------

The following information was extracted from each included study: name of the first author, year of publication, country and ethnicity of study subjects, type of CHD, genotypic frequencies of *MTRR* and/or *MTHFR* gene polymorphisms in cases and controls, and whether the distributions of investigated gene polymorphisms in the control group violated Hardy--Weinberg equilibrium (HWE).

The Newcastle--Ottawa scale (NOS), a classical assessment tool of observational studies that evaluates the quality of articles from three dimensions: selection, comparability and exposure, was adopted to assess the quality of included studies \[[@B18]\]. The NOS has a score range of 0 to 9, and studies with a score of more than 7 were considered to be of high quality.

Two reviewers (Aiping Xu and Weiping Wang) conducted data extraction and quality assessment independently. When necessary, the reviewers wrote to the corresponding authors for extra information or raw data. Disagreements between two reviewers were solved by discussion with the third reviewer (Xiaolei Jiang) until a consensus was reached.

Statistical analysis {#sec2-3}
--------------------

All data analyses in the present study were carried out using Review Manager Version 5.3.3 (The Cochrane Collaboration, Software Update, Oxford, United Kingdom). The probability value (*P* value) of HWE in the control group was calculated with the chi-square test. ORs and 95% CIs were used to estimate potential associations of *MTRR* and/or *MTHFR* gene polymorphisms with the risk of CHD in the dominant, recessive, additive and allele models, and a *P* value of 0.05 or less was considered as statistically significant. The *Q* test and *I*^2^ statistic were adopted to assess between-study heterogeneity. If *P* value of *Q* test was less than 0.1 or *I*^2^ was greater than 50%, random-effect models would be applied for analyses due to the existence of obvious heterogeneity. Otherwise, fixed-effect models would be employed for analyses. Subgroup analyses were subsequently performed according to ethnicity of study participants and type of disease. Sensitivity analyses were conducted to test the stability of the results. Publication bias was evaluated with funnel plots.

Results {#sec3}
=======

Characteristics of included studies {#sec3-1}
-----------------------------------

The literature search identified 311 citations. After exclusion of irrelevant and duplicate articles by reading titles and abstracts, 72 articles were selected for further evaluation. Another 25 articles were subsequently excluded after reading full texts, and a total of 47 studies that met the inclusion criteria were finally included in our meta-analysis (see [Figure 1](#F1){ref-type="fig"}). Characteristics of included studies were summarized in [Table 1](#T1){ref-type="table"}.

![Flowchart of study selection for the present study](bsr-38-bsr20181160-g1){#F1}

###### The characteristics of included studies

  First author, year       Country       Ethnicity   Sex, male (%) Case/ Control   Age (years) Case/ Control   Type of disease   Sample size   Genotype distribution   *P*-value for HWE   NOS score   
  ------------------------ ------------- ----------- ----------------------------- --------------------------- ----------------- ------------- ----------------------- ------------------- ----------- ---
  **rs1801394**                                                                                                                                                                                        
  Benke, 2015              Hungry        Caucasian   59.2/61.5                     2.42/3.08                   CHD               72/117        64/7/1                  110/6/1             0.016       7
  Christensen, 2013        Canada        Mixed       NA                            NA                          CHD               245/65        68/123/54               22/32/11            0.912       7
  Gong, 2010               China         Asian       NA                            NA                          CHD               60/60         38/21/1                 52/6/2              0.007       7
  Guo, 2017                China         Asian       NA                            2.31/2.48                   CHD               99/114        44/46/9                 67/44/3             0.174       8
  Guo, 2017                China         Asian       NA                            2.33/2.47                   VSD               21/114        7/11/3                  67/44/3             0.174       8
  Hassan, 2017             Egypt         Caucasian   36.0/32.0                     1.30/1.28                   CHD               100/100       26/32/42                48/36/16            0.048       8
  Liu, 2007                China         Asian       48.5/NA                       6.50/NA                     CHD               132/107       33/84/15                52/45/10            0.953       7
  Locke, 2010              U.S.A.        Mixed       NA                            NA                          CHD               92/94         27/50/15                31/46/17            0.993       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          CHD               153/147       46/74/33                61/63/23            0.323       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          VSD               74/147        24/32/18                61/63/23            0.323       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          TOF               79/147        22/42/15                61/63/23            0.323       7
  Pishva, 2013             Iran          Caucasian   46.3/44.8                     4.51/5.43                   VSD               123/125       41/54/28                62/53/10            0.776       7
  Su, 2017                 China         Asian       NA                            NA                          VSD               183/201       68/97/18                107/85/9            0.120       8
  van Beynum, 2006         Netherlands   Caucasian   NA                            NA                          CHD               159/245       51/83/25                74/124/47           0.699       7
  Verkleij-Hagoort, 2008   Netherlands   Caucasian   NA                            1.40/1.39                   CHD               229/251       79/112/38               77/122/52           0.774       7
  Wang, 2013               China         Asian       NA                            NA                          CHD               160/188       90/59/11                105/71/12           0.999       7
  Wang, 2018               China         Asian       NA                            2.18/1.81                   CHD               102/100       51/39/12                75/21/4             0.126       7
  Weine, 2012              Russia        Caucasian   NA                            2.15/2.11                   CHD               51/390        19/23/9                 128/191/71          0.986       7
  Zeng, 2011               China         Asian       43.4/47.2                     NA                          CHD               599/672       309/234/56              375/253/44          0.880       8
  Zhao, 2012               China         Asian       52.4/54.4                     6.59/6.59                   CHD               2340/2270     1308/860/172            1294/818/158        0.067       8
  **rs1532268**                                                                                                                                                                                        
  Hassan, 2017             Egypt         Caucasian   36.0/32.0                     1.30/1.28                   CHD               100/100       14/40/46                38/36/26            0.007       8
  Pishva, 2013             Iran          Caucasian   46.3/44.8                     4.51/5.43                   VSD               123/125       53/50/20                66/54/5             0.134       7
  Su, 2017                 China         Asian       NA                            NA                          VSD               183/201       66/96/21                105/80/16           0.889       8
  Zeng, 2011               China         Asian       43.4/47.2                     NA                          CHD               599/672       383/201/15              476/176/20          0.450       8
  **rs1801131**                                                                                                                                                                                        
  Božović, 2011            Croatia       Caucasian   49.1/49.3                     1.03/2.78                   CHD               54/221        30/22/2                 101/98/22           0.803       7
  Brandalize, 2009         Brazil        African     NA                            NA                          CHD               239/197       143/84/12               113/76/8            0.275       8
  Chao, 2014               Taiwan        Asian       11.8/38.2                     46.7/50.9                   PDA               17/34         13/2/2                  15/19/0             0.024       8
  Christensen, 2013        Canada        Mixed       NA                            NA                          CHD               246/65        133/93/20               36/22/7             0.212       7
  Feng, 2016               China         Asian       46.3/63.2                     1.3/1.9                     CHD               257/49        194/51/12               35/14/0             0.243       7
  Galdieri, 2007           Brazil        African     NA                            NA                          CHD               57/38         35/21/1                 19/16/3             0.884       7
  Guo, 2017                China         Asian       NA                            2.31/2.48                   CHD               99/114        71/28/0                 89/24/1             0.655       8
  Guo, 2017                China         Asian       NA                            2.33/2.48                   VSD               21/114        14/7/0                  89/24/1             0.655       8
  Huang, 2014              China         Asian       56.1/57.5                     2.54/2.70                   TOF               170/206       111/56/3                146/54/6            0.712       8
  Koshy, 2015              India         Caucasian   NA                            NA                          CHD               96/100        27/32/37                58/20/22            \<0.001     7
  Locke, 2010              U.S.A.        Mixed       NA                            NA                          CHD               87/88         42/39/6                 30/49/9             0.090       7
  Obermann-Borst, 2011     Netherlands   Caucasian   60.8/55.9                     17.0/17.3                   CHD               139/183       69/57/13                75/90/18            0.227       8
  Sahiner, 2014            Turkey        Caucasian   57.1/NA                       7.63/NA                     CHD               137/93        45/68/24                31/54/8             0.022       8
  Sayin Kocakap, 2015      Turkey        Caucasian   NA                            NA                          CHD               69/99         20/36/13                51/37/11            0.288       8
  Shi, 2015                China         Asian       38.85/57.41                   2.18/2.12                   CHD               153/216       95/39/19                157/53/6            0.555       7
  Storti, 2003             Italy         Caucasian   NA                            2.50/2.58                   CHD               100/100       43/46/11                50/43/7             0.582       7
  van Driel, 2008          Netherlands   Caucasian   58.0/57.0                     1.40/1.39                   CHD               230/251       104/102/24              116/104/31          0.311       8
  Wang, 2018               China         Asian       NA                            2.18/1.81                   CHD               102/100       57/40/5                 60/36/4             0.624       7
  Xu, 2010                 China         Asian       53.7/53.0                     6.50/6.69                   CHD               502/527       316/168/18              326/185/16          0.091       8
  Xu, 2010                 China         Asian       NA                            NA                          VSD               257/527       169/86/2                326/185/16          0.091       8
  Xu, 2010                 China         Asian       NA                            NA                          ASD               41/527        21/16/4                 326/185/16          0.091       8
  Zidan, 2013              Egypt         Caucasian   NA                            NA                          CHD               80/80         16/27/37                30/26/24            0.002       7
  **rs1801133**                                                                                                                                                                                        
  Božović, 2011            Croatia       Caucasian   49.1/49.3                     1.03/2.78                   CHD               54/221        20/28/6                 101/97/23           0.968       7
  Brandalize, 2009         Brazil        African     NA                            NA                          CHD               239/197       94/113/32               86/93/18            0.313       8
  Chao, 2014               Taiwan        Asian       11.8/38.2                     46.7/50.9                   PDA               17/34         10/5/2                  19/12/3             0.586       8
  Christensen, 2013        Canada        Mixed       NA                            NA                          CHD               246/65        94/117/35               27/29/9             0.787       7
  Feng, 2016               China         Asian       46.3/63.2                     1.3/1.9                     CHD               257/49        122/114/21              21/22/6             0.949       7
  Galdieri, 2007           Brazil        African     NA                            NA                          CHD               58/38         30/21/7                 18/14/6             0.263       7
  Gong, 2012               China         Asian       65.5/61.8                     1.91/1.58                   CHD               244/136       45/123/76               43/72/21            0.309       9
  Gong, 2012               China         Asian       61.6/61.8                     1.55/1.58                   TOF               120/136       21/59/40                43/72/21            0.309       9
  Gong, 2012               China         Asian       69.4/61.8                     2.27/1.58                   TGA               124/136       24/64/36                43/72/21            0.309       9
  Guo, 2017                China         Asian       NA                            2.31/2.48                   CHD               99/114        20/41/38                36/48/30            0.097       8
  Guo, 2017                China         Asian       NA                            2.33/2.48                   VSD               21/114        8/8/5                   36/48/30            0.097       8
  Huang, 2014              China         Asian       56.1/57.5                     2.54/2.70                   TOF               168/204       63/45/60                84/72/48            \<0.001     8
  Jiang, 2015              China         Asian       NA                            2.34/2.35                   CHD               100/100       38/46/16                41/48/11            0.523       7
  Jing, 2013               China         Asian       NA                            NA                          CHD               104/208       16/42/46                55/114/39           0.139       7
  Junker, 2001             Germany       Caucasian   53.0/NA                       16.0/NA                     CHD               114/228       51/42/21                129/78/21           0.075       7
  Koshy, 2015              India         Caucasian   63.5/49.0                     6.51/7.61                   CHD               96/90         95/1/0                  83/7/0              0.701       7
  Kuehl, 2010              U.S.A.        Mixed       50.4/56.0                     NA                          CHD               55/300        12/33/10                134/134/32          0.861       8
  Lee, 2005                Taiwan        Asian       NA                            NA                          CHD               213/195       110/89/14               114/68/13           0.513       7
  Li, 2005                 China         Asian       48.4/57.2                     NA                          CHD               183/103       30/95/58                22/57/24            0.277       7
  Li, 2013                 China         Asian       54.2/57.1                     2.68/2.79                   CHD               144/168       26/52/66                49/84/35            0.928       7
  Liu, 2007                China         Asian       48.5/NA                       6.5/NA                      CHD               132/107       30/68/34                46/48/13            0.930       7
  Locke, 2010              U.S.A.        Mixed       NA                            NA                          CHD               91/94         38/39/14                49/37/8             0.787       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          CHD               153/147       95/51/7                 100/46/1            0.078       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          VSD               74/147        24/32/18                100/46/1            0.078       7
  Noori, 2017              Iran          Caucasian   NA                            NA                          TOF               79/147        22/42/15                100/46/1            0.078       7
  Obermann-Borst, 2011     Netherlands   Caucasian   60.8/55.9                     1.41/1.44                   CHD               139/183       64/66/9                 92/76/15            0.900       8
  Sahiner, 2014            Turkey        Caucasian   57.1/NA                       7.63/NA                     CHD               136/93        69/53/14                47/39/7             0.779       8
  Sayin Kocakap, 2015      Turkey        Caucasian   NA                            NA                          CHD               75/95         40/33/2                 43/44/8             0.484       8
  Shaw, 2005               China         Asian       NA                            NA                          CHD               153/434       69/68/16                202/180/52          0.227       7
  Shi, 2015                China         Asian       38.85/57.41                   2.18/2.12                   CHD               153/216       55/68/30                70/101/45           0.444       7
  Storti, 2003             Italy         Caucasian   NA                            2.50/2.58                   CHD               100/100       27/53/20                26/54/20            0.401       7
  van Beynum, 2006         Netherlands   Caucasian   55.0/49.0                     3.4/9.4                     CHD               158/261       72/68/18                131/107/23          0.863       7
  van Driel, 2008          Netherlands   Caucasian   58.0/57.0                     1.40/1.39                   CHD               229/251       99/103/27               119/107/25          0.895       8
  Wang, 2013               China         Asian       NA                            NA                          CHD               160/188       59/76/25                53/100/35           0.312       7
  Wang, 2016               China         Asian       NA                            NA                          CHD               147/168       14/73/60                49/84/35            0.928       8
  Wang, 2018               China         Asian       NA                            2.18/1.83                   CHD               102/100       31/58/13                55/42/3             0.130       7
  Xu, 2010                 China         Asian       53.7/53.0                     6.50/6.69                   CHD               502/527       162/244/96              151/261/115         0.911       8
  Xu, 2010                 China         Asian       NA                            NA                          VSD               257/527       83/130/44               151/261/115         0.911       8
  Xu, 2010                 China         Asian       NA                            NA                          ASD               41/527        12/17/12                151/261/115         0.911       8
  Xu, 2013                 China         Asian       64.8/52.4                     NA                          CHD               228/230       73/106/49               124/74/32           \<0.001     8
  Yan, 2003                China         Asian       NA                            NA                          CHD               187/103       32/97/58                22/57/24            0.277       7
  Zhou, 2012               China         Asian       48.5/57.8                     NA                          TOF               136/277       23/60/53                88/126/63           0.168       8
  Zhu, 2006                China         Asian       35.1/57.7                     6.2/8.4                     CHD               56/103        7/22/27                 22/57/24            0.277       7
  Zhu, 2006                China         Asian       NA                            NA                          ASD               22/103        3/7/12                  22/57/24            0.277       7
  Zhu, 2006                China         Asian       NA                            NA                          PDA               34/103        4/15/15                 22/57/24            0.277       7
  Zidan, 2013              Egypt         Caucasian   NA                            NA                          CHD               80/80         18/21/41                32/21/27            \<0.001     7

Abbreviations: ASD, atrial septal defect; CHD, congenital heart disease; HWE, Hardy--Weinberg equilibrium; NA, not available; NOS, Newcastle--Ottawa scale; PDA, patent ductus arteriosus; TGA, transposition of the great arteries; TOF, tetralogy of fallot; VSD, ventricular septal defect.

Overall and subgroup analyses for *MTRR* polymorphisms {#sec3-2}
------------------------------------------------------

To investigate potential associations between *MTRR* gene polymorphisms and the risk of CHD, 17 studies about rs1801394 polymorphism and 4 studies about rs1532268 polymorphism were enrolled for overall analyses. Significant associations with the risk of CHD were detected for rs1801394 (dominant model: *P*=0.0001, OR = 0.68, 95%CI 0.56--0.83; recessive model: *P*=0.009, OR = 1.40, 95%CI 1.09--1.79; additive model: *P*=0.008, OR = 1.12, 95%CI 1.03-1.21; allele model: *P*=0.0001, OR = 0.73, 95%CI 0.63--0.86) and rs1532268 (dominant model: *P*=0.001, OR = 0.56, 95%CI 0.39--0.80; additive model: *P*=0.0009, OR = 1.36, 95%CI 1.13--1.63; allele model: *P*=0.0006, OR = 0.61, 95%CI 0.47--0.81) polymorphisms in overall analyses. Further subgroup analyses according to ethnicity of study participants demonstrated that the rs1801394 polymorphism was significantly correlated with the risk of CHD only in Asians, whereas the rs1532268 polymorphism was significantly correlated with the risk of CHD in both Asians and Caucasians. When we stratified data based on type of disease, we found that both rs1801394 and rs1532268 polymorphisms were significantly associated with the risk of VSD (see [Table 2](#T2){ref-type="table"} and Supplementary Figure S1).

###### Results of overall and subgroup analyses

  Population      Sample size   Dominant comparison   Recessive comparison    Additive comparison   Allele comparison                                                                                                                       
  --------------- ------------- --------------------- ----------------------- --------------------- ------------------- ----------------------- --------- ------------ ----------------------- ----- -------------- ----------------------- -----
  **rs1801394**                                                                                                                                                                                                                             
  Overall         4899/5246     **0.0001**            **0.68 (0.56--0.83)**   72%                   **0.009**           **1.40 (1.09--1.79)**   56%       **0.008**    **1.12 (1.03--1.21)**   48%   **0.0001**     **0.73 (0.63--0.86)**   77%
  Caucasian       887/1375      0.11                  0.75 (0.52--1.07)       68%                   0.18                1.45 (0.85**--**2.49)   76%       0.62         1.05 (0.87**--**1.26)   0%    0.10           0.75 (0.53**--**1.06)   84%
  Asian           3675/3712     **0.0008**            **0.60 (0.45--0.81)**   82%                   **0.02**            **1.24 (1.04--1.48)**   34%       **0.006**    **1.43 (1.11--1.85)**   74%   **0.0007**     **0.69 (0.55--0.85)**   79%
  VSD             558/587       **\<0.0001**          **0.55 (0.43--0.69)**   0%                    **\<0.0001**        **2.22 (1.51--3.26)**   15%       **0.02**     **1.32 (1.04--1.66)**   0%    **\<0.0001**   **0.60 (0.51--0.72)**   0%
  **rs1532268**                                                                                                                                                                                                                             
  Overall         1005/1098     **0.001**             **0.56 (0.39--0.80)**   64%                   0.06                1.83 (0.96**--**3.48)   68%       **0.0009**   **1.36 (1.13--1.63)**   23%   **0.0006**     **0.61 (0.47--0.81)**   68%
  Caucasian       223/225       0.08                  0.44 (0.18--1.09)       78%                   **\<0.0001**        **2.93 (1.77--4.88)**   16%       0.94         1.02 (0.70**--**1.48)   0%    **\<0.0001**   **0.50 (0.38--0.66)**   46%
  Asian           782/873       **0.008**             **0.64 (0.46--0.89)**   52%                   0.65                1.12 (0.69**--**1.80)   29%       **0.0002**   **1.48 (1.21--1.83)**   0%    **0.0007**     **0.75 (0.63--0.88)**   33%
  VSD             306/326       **\<0.0001**          **0.58 (0.42--0.79)**   0%                    0.11                2.48 (0.82**--**7.52)   70%       0.47         1.25 (0.68**--**2.28)   71%   **\<0.0001**   **0.62 (0.49--0.79)**   0%
  **rs1801131**                                                                                                                                                                                                                             
  Overall         2834/2761     0.44                  0.93 (0.76--1.13)       63%                   **0.003**           **1.36 (1.11--1.67)**   **42%**   0.88         0.99 (0.88**--**1.11)   38%   0.23           0.90 (0.75**--**1.07)   72%
  Caucasian       905/1127      0.14                  0.74 (0.49--1.10)       78%                   **0.01**            **1.40 (1.08--1.81)**   **45%**   0.62         1.05 (0.87**--**1.26)   43%   0.10           0.77 (0.57**--**1.05)   81%
  Asian           1300/1246     0.75                  0.97 (0.82--1.15)       23%                   **0.009**           **1.78 (1.15--2.75)**   **47%**   0.97         0.99 (0.74**--**1.34)   55%   0.42           0.89 (0.68**--**1.18)   64%
  VSD             601/641       0.95                  0.99 (0.79--1.25)       21%                   0.74                1.12 (0.58**--**2.18)   0%        0.96         0.99 (0.78**--**1.26)   44%   0.88           0.98 (0.81**--**1.20)   0%
  **rs1801133**                                                                                                                                                                                                                             
  Overall         5508/6207     **\<0.0001**          **0.73 (0.63--0.84)**   62%                   **\<0.0001**        **1.54 (1.30--1.83)**   59%       0.86         1.01 (0.93**--**1.09)   86%   **\<0.0001**   **0.75 (0.67--0.84)**   73%
  Caucasian       1334/1749     **0.02**              **0.83 (0.72--0.97)**   26%                   **0.01**            **1.35 (1.06--1.72)**   28%       0.42         1.06 (0.91**--**1.24)   0%    **0.004**      **0.84 (0.75--0.95)**   50%
  Asian           3485/3764     **\<0.0001**          **0.67 (0.55--0.83)**   73%                   **\<0.0001**        **1.66 (1.32--2.10)**   71%       0.43         0.96 (0.87**--**1.06)   48%   **\<0.0001**   **0.70 (0.60--0.83)**   81%
  TOF             701/764       **0.0001**            **0.63 (0.50--0.80)**   48%                   **\<0.0001**        **2.17 (1.66--2.84)**   0%        0.28         0.89 (0.71**--**1.10)   0%    **\<0.0001**   **0.62 (0.53--0.72)**   4%
  VSD             754/788       0.48                  0.85 (0.54--1.33)       68%                   0.37                1.43 (0.65**--**3.14)   75%       0.90         0.99 (0.81**--**1.21)   0%    0.36           0.82 (0.54**--**1.25)   80%

Abbreviations: ASD, atrial septal defect; CHD, congenital heart disease; CI, confidence interval; NA, not available; OR, odds ratio; PDA, patent ductus arteriosus; TOF, tetralogy of fallot; VSD, ventricular septal defect.

The values in bold represent there is statistically significant differences between cases and controls.

Overall and subgroup analyses for *MTHFR* polymorphisms {#sec3-3}
-------------------------------------------------------

To investigate potential associations between *MTHFR* gene polymorphisms and the risk of CHD, 19 studies about rs1801131 polymorphism and 37 studies about rs1801133 polymorphism were enrolled for overall analyses. Significant associations with the risk of CHD were detected for rs1801131 (recessive model: *P*=0.003, OR = 1.36, 95%CI 1.11--1.67) and rs1801133 (dominant model: *P*\<0.0001, OR = 0.73, 95%CI 0.63--0.84; additive model: *P*\<0.0001, OR = 1.54, 95%CI 1.30--1.83; allele model: *P*\<0.0001, OR = 0.75, 95%CI 0.67--0.84) polymorphisms in overall analyses. Further subgroup analyses according to ethnicity of study participants demonstrated that rs1801133 and rs1801131 polymorphisms were significantly correlated with the risk of CHD in both Asians and Caucasians. When we stratified data based on type of disease, we found that the rs1801133 polymorphism was significantly associated with the risk of TOF (see [Table 2](#T2){ref-type="table"} and Supplementary Figure S1).

Sensitivity analyses {#sec3-4}
--------------------

To examine stabilities of synthetic results, sensitivity analyses were further performed by removing studies that departed from HWE. No changes of results were detected for investigated gene polymorphisms in any comparisons, which indicated that our findings were quite statistically stable.

Publication biases {#sec3-5}
------------------

Funnel plots were used to assess potential publication biases in the present study. No apparent asymmetry of funnel plots was observed in any comparisons, which suggested that our findings were unlikely to be influenced by obvious publication biases (see Supplementary Figure S2).

Discussion {#sec4}
==========

CHD contain various structural cardiovascular malformations that are actually or potentially of functional significances \[[@B19]\]. Historically, few CHD patients reached adulthood, but thanks to enormous advances in interventional therapies and surgical treatments over the past few years, the average life expectancy of CHD patients has been significantly improved \[[@B20]\]. However, despite substantially improved prognosis, CHD remains to be the leading cause of infant deaths all over the world.

MTHFR and MTRR are fundamental regulatory enzymes of folate and homocysteine metabolism. Considering the consistently observed association between folic acid consumption and a reduced risk of cardiac deformity, functional polymorphisms of *MTHFR* and *MTRR*, which were known to be associated with altered enzymatic activities, were thought to be correlated with the risk of CHD \[[@B11],[@B12]\]. Recently, several studies have tried to explore the potential associations of functional *MTHFR* and *MTRR* gene polymorphisms with the risk of CHD, but the results of these studies were inconsistent. Therefore, we conducted the present meta-analysis to obtain a more conclusive result. Our overall analyses suggested that *MTRR* rs1801394, *MTRR* rs1532268, *MTHFR* rs1801131 and *MTHFR* rs1801133 polymorphisms were all significantly associated with the risk of CHD in certain genetic models. Further subgroup analyses according to ethnicity of study participants demonstrated that the *MTRR* rs1801394 polymorphism was significantly correlated with the risk of CHD only in Asians, whereas *MTRR* rs1532268, *MTHFR* rs1801133 and *MTHFR* rs1801131 polymorphisms were significantly correlated with the risk of CHD in both Asians and Caucasians. When we stratified data based on type of disease, we found that both *MTRR* rs1801394 and *MTRR* rs1532268 polymorphisms were significantly associated with the risk of VSD, whereas the *MTHFR* rs1801133 polymorphism was significantly associated with the risk of TOF. The stabilities of synthetic results were subsequently evaluated in sensitivity analyses, and no changes of results were observed in any comparisons, which indicated that our findings were quite stable and reliable. It is noteworthy that obvious between-study heterogeneities were detected in several comparisons. However, a great reduction in heterogeneities was found in further stratified analyses, which suggested that differences in ethnic background and type of disease could partially explain the observed heterogeneities.

Our meta-analysis is certainly not without limitations. First, our results were based on unadjusted estimations, and lack of analyses adjusted for potential confounding factors such as age, sex and co-morbidity conditions may impact the reliability of our findings. Second, heterogeneity remained significant in certain subgroups, which suggested that the conflicting results of eligible studies could not be fully explained by differences in ethnicity of study population or type of CHD, and other unmeasured characteristics of study participants may also attribute to the observed between-study heterogeneities. Third, associations between investigated polymorphisms and the risk of CHD may also be influenced by gene--gene and gene--environmental interactions. However, we failed to analyze the effect of these interactions in our study because only very little relevant data were provided by enrolled literatures. Taken these limitations into consideration, the results obtained by the present study should be interpreted with caution.

In conclusion, the current meta-analysis indicated that *MTRR* rs1801394, *MTRR* rs1532268, *MTHFR* rs1801131 and *MTHFR* rs1801133 polymorphisms may affect the risk of CHD in Asians and Caucasians, while the *MTRR* rs1801394 polymorphism may only affect in risk of CHD in Asians. However, it is notable that relevant studies were still at the early stage and further well-designed studies are still warranted to confirm our findings.
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CHD

:   congenital heart diseases

CI

:   confidence interval

HWE

:   Hardy--Weinberg equilibrium

MTHFR

:   methylenetetrahydrofolate reductase

MTRR

:   methionine synthase reductase

NOS

:   Newcastle--Ottawa scale

OR

:   odds ratio
